By Metro US
Posted on
CAPE TOWN (Reuters) – South Africa’s Biovac Institute is aiming to start production of the mRNA COVID-19 vaccine developed by Pfizer and BioNTech in the second half of next year, its chief executive officer said on Wednesday.
Morena Makhoana told Reuters the Cape Town-based firm would ramp up production of the COVID-19 vaccine before reaching output of 100 million doses a year around early 2023.
(Reporting by Wendell Roelf; Editing by Alexander Winning)
Paul McCartney song starts Paralympics on 100-day countdown to opening ceremony in Paris
Oilers beat Canucks 5-1 to force deciding Game 7 in second-round series
Hart, Anunoby listed as questionable to play for Knicks on Sunday in Game 7 against the Pacers
Nelly Korda seizes 2-shot lead at Mizuho Americas Open, inches closer to 6th win in 7 events
P.J. Washington’s free throws finish rally as Mavericks beat Thunder 117-116 to reach West finals
An airstrike kills 20 in central Gaza and fighting rages as Israel’s leaders air wartime divisions
Brooklyn double shooting leaves man dead, another wounded in precinct with soaring murder, shooting rates
Senior Republican close to Trump criticizes Biden’s arms holdup in speech to Israeli parliament
At least 10 killed as Russia presses forward with its offensive in northeastern Ukraine
What we’ve learned so far in the Trump hush money trial and what to watch for as it wraps up
The Senate filibuster is a hurdle to any national abortion bill. Democrats are campaigning on it
What happened in the UK’s infected blood scandal? Inquiry report will be revealed on Monday
Water, water everywhere … most is now safe to drink in an English village after parasite outbreak
For decades, states have taken foster children’s federal benefits. That’s starting to change
